This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90011177
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 19 квітня 2019 artículu científicu espublizáu n'abril de 2019 wetenschappelijk artikel scientific article published on 19 April 2019
p:P577
wds:Q90011177-67E67B47-62C0-4CF3-8442-FAF89914D56D
wdt:P577
2019-04-19T00:00:00Z
p:P2093
wds:Q90011177-B81EEC8C-8356-4CA8-B3C3-B1BC0FEF18D7 wds:Q90011177-AA2D4B59-9A1B-4720-91F9-D7A4E793C4F3 wds:Q90011177-A6636415-3E55-4C4B-BD4E-DC6E2BCC0942
wdt:P2093
Antonio Greco Petronilla Battista Antonio Daniele
rdfs:label
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
skos:prefLabel
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
schema:name
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
p:P50
wds:Q90011177-A207A89B-3130-4E3F-9A47-40C96BA003E9 wds:Q90011177-013D30C7-B207-4C83-B0C9-405AA07C34A5 wds:Q90011177-070F3700-D20A-41E8-8DA2-8E55439928B3 wds:Q90011177-25909F53-9797-408F-A85F-FA2299CD8D4D wds:Q90011177-DF1B0E33-4458-4692-A8F4-E02FE9A5D5C9 wds:Q90011177-0A16A58E-19B6-4B5D-8AF2-2D839F996296 wds:Q90011177-DB3803AB-6F62-4EFB-BC23-494DFE454DF6 wds:Q90011177-F125698D-FA21-4001-9B73-BA4BF6E2DA01 wds:Q90011177-3B2B7512-3418-4635-9D0D-445E8142AEC3 wds:Q90011177-36D6C542-0B81-42BC-B01D-97B1480B2383 wds:Q90011177-553E1586-A043-48F1-ADAD-82F0ABA47A9B
wdt:P50
wd:Q37837797 wd:Q88121271 wd:Q67487574 wd:Q56972634 wd:Q114342893 wd:Q37830901 wd:Q57569304 wd:Q57003161 wd:Q114342901 wd:Q88370620 wd:Q91908373
p:P1476
wds:Q90011177-36D14F55-A039-48F0-AE21-34E45E19928E
wdt:P1476
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
p:P304
wds:Q90011177-01DD3191-C24B-4BE7-BA74-251498E25B81
wdt:P304
1091-1107
p:P31
wds:Q90011177-FF6D5EFE-5185-414C-80C9-180CEADAAB2C
wdt:P31
wd:Q13442814
p:P921
wds:Q90011177-FFF90531-1008-4E1B-B4A0-614F9A8212B3
wdt:P921
wd:Q18592
p:P698
wds:Q90011177-AC826D60-0015-410F-BDD8-EA76CCAB719A
wdtn:P698
n10:31002267
wdt:P698
31002267
p:P1433
wds:Q90011177-3086562B-F0B0-4F0C-8650-3041E998B6E5
wdt:P1433
wd:Q5421212
p:P433
wds:Q90011177-6578BCC2-B2E7-404E-A9D5-DC1A70B428B4
p:P478
wds:Q90011177-6A18FBB4-7243-4EAA-81C9-3935BBF869AB
wdt:P433
9
wdt:P478
20
p:P356
wds:Q90011177-644E95C4-A6AE-4AD2-A0C7-8B90A44A953A
wdtn:P356
n12:14656566.2019.1598377
wdt:P356
10.1080/14656566.2019.1598377